Merck's (MRK) monoclonal antibody clesrovimab shows cuts RSV infections by 60% in infants, with a strong safety profile. Read ...

WellSpan Ephrata Community Hospital is now offering respiratory syncytial virus immunizations to infants born at the hospital ...

RSV is a virus that can make people sick, especially older adults and babies. But even though RSV can be serious, people aren ...

RSV, or Respiratory Syncytial Virus, is a highly contagious virus that frequently spreads among preschool children, ...

Cold and flu season — otherwise known as mid-October — is upon us. But this year, several advancements in vaccines could help ...

MOBILE, Ala. ( WALA) - At USA Health Children’s & Women’s Hospital, doctors are seeing a rise in pediatric RSV cases. Dr.

Merck’s investigational antibody clesrovimab demonstrated more than 60% effectiveness in reducing some types of respiratory ...

Respiratory Illness season is right around the corner and experts are urging parents to take action to protect their newborns ...

Health experts highlight how this highly contagious disease affects vulnerable populations and share insights on prevention ...

Public worry about getting RSV has dropped significantly since the fall of 2023, though RSV remains a concern for infants and ...

Ziresovir, an antiviral drug targeted at respiratory syncytial virus (RSV), was superior to placebo in reducing signs and ...

Adults who are at risk of severe RSV are 75 years or older. Also, people between 60 and 74 years old who have chronic health ...